The Swiss Medical Board is a leading Swiss centre of competence in health technology assessment. It analyses and assesses preventive and diagnostic procedures and therapeutic interventions from the perspective of medicine, economic considerations, ethics and law. On this basis, it develops recommendations to political decision-makers, medical specialists and other service providers. In selected cases, information leaflets are also published for patients.
The sponsoring membership of the Swiss Medical Board (SMB) includes the following institutions and bodies: Konferenz der kantonalen GesundheitsdirektorInnen – GDK (the Swiss conference of cantonal ministers of public health), Schweizerische Akademie der Medizinischen Wissenschaften – SAMW (Swiss academy of medical sciences), the Government of the Principality of Lichtenstein, interpharma (the association of pharmaceutical research companies of Switzerland), associations of health insurers (santésuisse, curafutura), patient organisations (Schweizerische Stiftung SPO Patientenschutz and Dachverband Schweizerischer Patientenstellen – DVSP), and fmCh (the umbrella organisation for doctors carrying out surgery and invasive procedures).